Taken together, these results suggest that CFH per se exerts antioxidant protective effects on RPE cells and that blocking the alternative complement pathway activation, without restoring the activity of CFH might not be sufficient to exert full preventive and therapeutic effects in AMD. The gene discussed is CFH; the disease is age-related macular degeneration.